First-order effects

• Huawei builds a defensive licensing portfolio on US soil even while barred from much of the US market, converting R&D spending into enforceable American intellectual property that survives the sanctions regime.
• US-based companies lose majority status among US patent recipients, weakening the assumption that domestic filings track domestic innovation leadership.

Second-order effects

• Samsung, Canon, TSMC, and IBM now anchor the top of the list while Chinese rivals climb behind them, pushing established holders toward volume-driven patent strategies they can no longer win on inertia alone.
• Huawei's growing US grant count gives it cross-licensing leverage over Western handset and networking vendors who need its standard-essential patents regardless of trade restrictions.

Third-order effects

• If the pattern holds, US export controls constrain what Chinese firms can sell into America but not what they can own there — patent law becoming a channel where geopolitical competition shows up as rising foreign share rather than exclusion.
• The rankings shift from a measure of corporate R&D prestige to a signal of where innovation capacity is geographically concentrating, with six of the top ten cybersecurity patent holders already Chinese by late 2023 per the related coverage.